Henrik Ancher-Jensen
Corporate Officer/Principal bij AGILENT TECHNOLOGIES, INC.
Vermogen: 8 M $ op 31-03-2024
Profiel
Henrik Ancher-Jensen is currently working as the SVP & President-Order Fulfillment & Supply Chain at Agilent Technologies, Inc. He previously worked as the Vice President-Global Operations at Dako Denmark ApS from 2010 to 2012.
Mr. Ancher-Jensen completed his undergraduate degree at the University of Aarhus.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
23-01-2024 | 54 713 ( 0.02% ) | 8 M $ | 31-03-2024 |
Actieve functies van Henrik Ancher-Jensen
Bedrijven | Functie | Begin |
---|---|---|
AGILENT TECHNOLOGIES, INC. | Corporate Officer/Principal | 01-09-2012 |
Eerdere bekende functies van Henrik Ancher-Jensen
Bedrijven | Functie | Einde |
---|---|---|
Dako Denmark ApS
Dako Denmark ApS Medical SpecialtiesHealth Technology Dako Denmark A/S designs and manufactures cancer diagnostic systems. It produces reagents, antibodies, instruments, and software solutions to make diagnoses and determine treatments for patients suffering from cancer. The firm's product areas encompass Immunohistochemistry, pharmacoDiagnostics, molecular pathology, Hematoxylin and Eosin stain, special stains, flow Cytometry, and specific proteins. The company was founded by Niels Harboe in 1966 and is headquartered in Glostrup, Denmark. | Chief Operating Officer | 01-09-2012 |
Opleiding van Henrik Ancher-Jensen
University of Aarhus | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
AGILENT TECHNOLOGIES, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Dako Denmark ApS
Dako Denmark ApS Medical SpecialtiesHealth Technology Dako Denmark A/S designs and manufactures cancer diagnostic systems. It produces reagents, antibodies, instruments, and software solutions to make diagnoses and determine treatments for patients suffering from cancer. The firm's product areas encompass Immunohistochemistry, pharmacoDiagnostics, molecular pathology, Hematoxylin and Eosin stain, special stains, flow Cytometry, and specific proteins. The company was founded by Niels Harboe in 1966 and is headquartered in Glostrup, Denmark. | Health Technology |